Key Drivers
- Strong Cash Flow
- Ample Liquidity
- Premium Valuation
AIAI Summary
LMAT's strong margins, free cash flow, and $375M+ liquidity cushion limit financial downside, but the investment case now hinges on proving that near-10% growth can consistently beat expectations and sustain its still-premium valuation; wait for a return above ~$80.80 or a clean earnings beat before treating the post-miss weakness as a buying opportunity.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Ample Liquidity
- •Premium Valuation
LMAT delivers strong profitability, liquidity, and cash flow, but its elevated valuation, modest asset turnover, and meaningful debt warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Weak monthly trend
- •Critical support test
- •Rebound trigger
LMAT remains weak over the last month; watch $78.80–$79.00 support, as a break lower would worsen momentum, while a move above $80.80 could signal a rebound.
Price repeatedly tested support after a roughly 4.2% monthly decline
Sentiment & News
Key News Insights:
- •Valuation comparison
- •Conference participation
- •No operating updates
LMAT is attracting valuation-focused investor attention while management boosts outreach through upcoming September conferences.
The news may modestly support investor interest, though it provides no new fundamental catalyst
Similar Companies in Healthcare
Other companies in the same sector with AI ratings